FDA Approves First Universal Allogeneic CAR-T Cell Therapy for Refractory Pancreatic Cancer
The FDA has approved Panca-Cel, the first universal allogeneic CAR-T cell therapy for refractory pancreatic cancer. Engi...
Read More →The FDA has approved Panca-Cel, the first universal allogeneic CAR-T cell therapy for refractory pancreatic cancer. Engi...
Read More →